Judge narrows Reckitt investor suit over opioid marketing | Secondary Sources | Westlaw

Judge narrows Reckitt investor suit over opioid marketing | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, Judge narrows Reckitt investor suit over opioid marketing, Secondary Sources
Skip Page Header

Judge narrows Reckitt investor suit over opioid marketing

2022 SECDBRF 0041By Nicole BanasWESTLAW Securities Enforcement & Litigation Daily Briefing (Approx. 3 pages)

Judge narrows Reckitt investor suit over opioid marketing

2022 SECDBRF 0041By Nicole BanasWESTLAW Securities Enforcement & Litigation Daily Briefing (Approx. 3 pages)

Judge narrows Reckitt investor suit over opioid marketing

(March 2, 2022) - Shareholders of Reckitt Benckiser Group PLC can proceed with part of a lawsuit claiming the U.K. health care company concealed an illicit marketing scheme for an opioid addiction treatment, a New York federal judge has ruled.
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.